The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' Energy & Commerce (E&C) Committee.

The companies will work to integrate Prevencio's protein-based blood tests into Quadrant's care pathways to better translate the results into clinical action and measure outcomes.

NEW YORK — Alpenglow Biosciences has partnered with digital pathology lab PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers, the companies said on Thursday.

Fox Chase will use Arima's 3D genomics technology as part of its diagnostic workflow for lymphoma and sarcoma.

Coupling biomarker-guided screening with a targeted treatment bundle reduced newborn mortality, hospital stays, and other complications over standard care, according to a recent study.

The funding will support final development, clinical validation, regulatory approval, and commercial launch of an ultra-rapid AST platform.

Aranscia will provide software solutions to facilitate the delivery of results from InterVenn's flagship glycoproteomic liquid biopsy test.

Of the 30 companies in the index, 20 saw their share prices decline, while four saw their stock prices rise and two were flat month over month.

Of the 30 companies in the index, 18 saw their share prices rise over the year, while 11 saw their stock prices decline and one remained flat.

The HRSA screening guidelines now recommend use of either clinician-collected or patient-collected samples for human papillomavirus testing.

The organization updated its guidelines to account for changes in the illegal drug supply as well as advances in technologies used for drug detection.

The rapid molecular chlamydia and gonorrhea self-test provides results in 30 minutes from a self-collected swab sample, the firm said.